1. |
Bene BA, O'Connor S, Mastellos N, et al. Impact of mobile health applications on self-management in patients with type 2 diabetes mellitus: protocol of a systematic review[J/OL]. BMJ Open, 2019, 9(6): e025714[2019-06-25]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597642/. DOI: 10.1136/bmjopen-2018-025714.
|
2. |
Li W, Jin L, Cui Y, et al. Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression[J]. J Endocrinol Invest, 2021, 44(6): 1193-1207. DOI: 10.1007/s40618-020-01405-3.
|
3. |
Louie HH, Shome A, Kuo CY, et al. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy[J/OL]. Exp Eye Res, 2021, 202: 108384[2020-12-05]. https://pubmed.ncbi.nlm.nih.gov/33285185/. DOI: 10.1016/j.exer.2020.108384.
|
4. |
Yu HS, Hong EH, Shin YU, et al. ATP-binding cassette subfamily A-1 (ABCA1) levels are increased in the aqueous humour of proliferative diabetic retinopathy patients[J/OL]. Acta Ophthalmol, 2021, 99(3): e442-443[2020-07-23]. https://pubmed.ncbi.nlm.nih.gov/32701222/. DOI: 10.1111/aos.14550.
|
5. |
Rallidis LS, Kosmas N, Rallidi T, et al. Homocysteine is an independent predictor of long-term cardiac mortality in patients with stable coronary artery disease in the era of statins[J]. Coron Artery Dis, 2020, 31(2): 152-156. DOI: 10.1097/MCA.0000000000000800.
|
6. |
Selvaraj S, Claggett BL, Pfeffer MA, et al. Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF[J]. Eur J Heart Fail, 2020, 22(11): 2093-2101. DOI: 10.1002/ejhf.1984.
|
7. |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1): 4-67. DOI: 10.3760/cma.j.issn.1674-5809.2018.01.003.Chinese Diabetes Society, Chinese Medical Association. Standards of care for type 2 diabetes in China[J]. Chin J Diabetes Mellitus, 2018, 10(1): 4-67. DOI: 10.3760/cma.j.issn.1674-5809.2018.01.003.
|
8. |
中华医学会眼科学会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014年)[J]. 中华眼科杂志, 2014, 50(11): 851-865. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.014.Fundus Diseases Group, Ophthalmology Society of Chinese Medical Association. Guidelines for clinical diagnosis and treatment of diabetes retinopathy in China (2014)[J]. Chin J Ophthalmol, 2014, 50(11): 851-865. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.014.
|
9. |
Dennis JM. Precision medicine in type 2 diabetes: using individualized prediction models to optimize selection of treatment[J]. Diabetes, 2020, 69(10): 2075-2085. DOI: 10.2337/dbi20-0002.
|
10. |
Li X, Xie J, Zhang L, et al. Identifying microvascular and neural parameters related to the severity of diabetic retinopathy using optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2020, 61(5): 39. DOI: 10.1167/iovs.61.5.39.
|
11. |
Lv X, Ran X, Chen X, et al. Early-onset type 2 diabetes: a high-risk factor for proliferative diabetic retinopathy (PDR) in patients with microalbuminuria[J/OL]. Medicine (Baltimore), 2020, 99(19): e20189[2020-05-01]. https://pubmed.ncbi.nlm.nih.gov/32384512/. DOI: 10.1097/MD.0000000000020189.
|
12. |
Seki H, Kaneko H, Morita H, et al. Relation of serum uric acid and cardiovascular events in young adults aged 20-49 years[J]. Am J Cardiol, 2021, 152: 150-157. DOI: 10.1016/j.amjcard.2021.05.007.
|
13. |
Ren Y, Gao L, Guo X, et al. Interactive effect of serum uric acid and total bilirubin for micro-vascular disease of type 2 diabetes in China[J]. J Diabetes Complications, 2018, 32(11): 1000-1005. DOI: 10.1016/j.jdiacomp.2018.09.002.
|
14. |
项杰, 张曙光, 陈素英, 等. 血尿酸、胱抑素C和促代谢因子水平与糖尿病视网膜病变的相关性分析[J]. 现代药物与临床, 2020, 35(11): 2144-2148. DOI: 10.7501/j.issn.1674-5515.2020.11.006.Xiang J, Zhang SG, Chen SY, et al. Correlation between levels of serum uric acid, cystatin C, and betatrophin and diabetic retinopathy[J]. Drugs & Clinic, 2020, 35(11): 2144-2148. DOI: 10.7501/j.issn.1674-5515.2020.11.006.
|
15. |
Zhu DD, Wang YZ, Zou C, et al. The role of uric acid in the pathogenesis of diabetic retinopathy based on Notch pathway[J]. Biochem Biophys Res Commun, 2018, 503(2): 921-929. DOI: 10.1016/j.bbrc.2018.06.097.
|
16. |
刘韵, 郭皖北, 曹明艳, 等. 胰岛素抗体阳性的2型糖尿病患者血清同型半胱氨酸水平变化的研究[J]. 中国糖尿病杂志, 2020, 28(1): 33-36. DOI: 10.3969/j.issn.1006-6187.2020.01.007.Liu Y, Guo WB, Cao MY, et al. Relationship between positive insulin antibody and serum homocysteine levels in patients with type 2 diabetes[J]. Chin J Diabetes, 2020, 28(1): 33-36. DOI: 10.3969/j.issn.1006-6187.2020.01.007.
|
17. |
Gupta P, John D, Rebekah G, et al. Role of hyperhomocysteinemia in proliferative diabetic retinopathy: a case-control study[J]. Indian J Ophthalmol, 2018, 66(10): 1435-1440. DOI: 10.4103/ijo.IJO_350_18.
|
18. |
钟欣静, 黄翠娟, 林蓓佑, 等. H型高血压病人同型半胱氨酸与血压变异性和血尿酸的相关性[J]. 中西医结合心脑血管病杂志, 2020, 18(6): 948-951. DOI: 10.12102/j.issn.1672-1349.2020.06.021.Zhong XJ, Huang CJ, Lin BY, et al. Correlation between homocysteine and blood pressure variability and serum uric acid in patients with type H hypertension[J]. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease, 2020, 18(6): 948-951. DOI: 10.12102/j.issn.1672-1349.2020.06.021.
|
19. |
徐菲菲, 刘咏梅, 房振宇, 等. 原发性肾小球肾炎患者血浆高同型半胱氨酸水平的变化及与钙磷乘积和血尿酸的相关性分析[J]. 现代生物医学进展, 2020, 20(3): 558-560, 548. DOI: 10.13241/j.cnki.pmb.2020.03.034.Xu FF, Liu YM, Fang ZY, et al. Changes of plasma Hcy in patients with primary glomerulonephritis and its correlation with calcium-phosphorus product and blood uric acid[J]. Progress in Modern Biomedicine, 2020, 20(3): 558-560, 548. DOI: 10.13241/j.cnki.pmb.2020.03.034.
|
20. |
Dong N, Shi H, Tang X. Plasma homocysteine levels are associated with macular thickness in type 2 diabetes without diabetic macular edema[J]. Int Ophthalmol, 2018, 38(2): 737-746. DOI: 10.1007/s10792-017-0528-0.
|
21. |
龚杰, 周波. 同型半胱氨酸和糖化血红蛋白水平与糖尿病视网膜病变的相关性[J]. 广西医学, 2019, 41(16): 2042-2044. DOI: 10.11675/j.issn.0253-4304.2019.16.09.Gong J, Zhou B. Correlation of homocysteine and hemoglobin A1 c levels with diabetic retinopathy[J]. Guangxi Medical Journal, 2019, 41(16): 2042-2044. DOI: 10.11675/j.issn.0253-4304.2019.16.09.
|
22. |
李红军, 刘有娅, 谭芳. 2型糖尿病视网膜病变患者凝血功能及危险因素分析[J]. 血栓与止血学, 2020, 26(2): 190-192. DOI: 10.3969/j.issn.1009-6213.2020.02.004.Li HJ, Liu YY, Tan F. Analysison coagulation function and risk factors of patients with type 2 diabetic retinopathy[J]. Chinese Journal of Thrombosis and Hemostasis, 2020, 26(2): 190-192. DOI: 10.3969/j.issn.1009-6213.2020.02.004.
|
23. |
朱夏媛, 吴浩, 葛彩英, 等. 社区2型糖尿病视网膜病变风险预测模型的构建与验证[J]. 中国全科医学, 2020, 23(6): 85-88. DOI: 10.12114/j.issn.1007-9572.2020.00.063.Zhu XY, Wu H, Ge CY, et al. Establishment and verification of a risk prediction model of diabetic retinopathy in patients with type 2 diabetes in the community[J]. Chinese General Practice, 2020, 23(6): 85-88. DOI: 10.12114/j.issn.1007-9572.2020.00.063.
|
24. |
柳洁平, 付艳广, 张俊广, 等. 血清ICAM-1、VEGF水平与糖尿病视网膜病变患者微血管损伤的关系[J]. 山东医药, 2020, 60(16): 47-49. DOI: 10.3969/j.issn.1002-266X.2020.16.012.Liu JP, Fu YG, Zhang JG, et al. The relationship between serum ICAM-1, VEGF levels and microvascular injury in patients with diabetes retinopathy[J]. Shandong Medical Journal, 2020, 60(16): 47-49. DOI: 10.3969/j.issn.1002-266X.2020.16.012.
|